戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ritical role in the inflammatory response to Gram-positive bacterial infection.
2 ammatory responses of primary macrophages to Gram-positive bacterial infection.
3 ammatory response and host defense against a gram-positive bacterial infection.
4 ort for the treatment of multidrug-resistant Gram-positive bacterial infections.
5 pposed to protective, role for IL-17A during Gram-positive bacterial infections.
6 rt for the treatment of antibiotic-resistant gram-positive bacterial infections.
7 in is an important drug for the treatment of Gram-positive bacterial infections.
8 ration of novel vaccine modalities to combat Gram-positive bacterial infections.
9 SOC antibiotics for the treatment of serious gram-positive bacterial infections.
10 fe antibiotic candidate for the treatment of Gram-positive bacterial infections.
11 in-resistant Staphylococcus aureus and other Gram-positive bacterial infections.
12 peptide antibiotic used for the treatment of Gram-positive bacterial infections.
13 ceptible to Gram-negative (E. coli), but not Gram-positive, bacterial infection.
14 he primary TLR2 ligand in the early phase of gram-positive bacterial infection and remains a major li
15  of sickness response in clinically manifest Gram-positive bacterial infections and may contribute to
16                               Drug-resistant Gram-positive bacterial infections are still a substanti
17         dawdle, in contrast, is activated by Gram-positive bacterial infection but repressed by Gram-
18 the treatment of serious multidrug-resistant Gram-positive bacterial infections caused by strains of
19 line antibiotic to treat multidrug-resistant Gram-positive bacterial infections, e.g., methicillin-re
20                Although the role of MCP-1 in gram-positive bacterial infections has been previously i
21 ncomycin, a glycopeptide antibiotic used for Gram-positive bacterial infections, has been linked with
22  results show that MC confer defense against Gram-positive bacterial infection in the skin, a functio
23  earliest steps in innate immune response to Gram-positive bacterial infection is poorly understood.
24                   However, its role in other Gram-positive bacterial infections is unclear.
25 st-resort antibiotics such as vancomycin for Gram-positive bacterial infections necessitates the deve
26  effective as step-down treatment of serious gram-positive bacterial infections, offering comparable
27                                              Gram-positive bacterial infections present a major clini
28 Herein, we summarize ARLG accomplishments in gram-positive bacterial infection research, including st
29 infective agents in the treatment of serious gram-positive bacterial infections, their usefulness is
30    The findings of this study suggest that a Gram-positive bacterial infection, through TLR2 and TLR1
31 e the physiological function of MKP-1 during Gram-positive bacterial infection, we studied the innate